Buscar
Tandem Diabetes Care Inc
TNDMAñadir a la lista de seguimiento
19.500USD
+0.490+2.58%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
1.34BCap. mercado
PérdidaP/E TTM
Más Datos de Tandem Diabetes Care Inc Compañía
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company that manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
Información de Tandem Diabetes Care Inc
Símbolo de cotizaciónTNDM
Nombre de la empresaTandem Diabetes Care Inc
Fecha de salida a bolsaNov 13, 2013
Director ejecutivoSheridan (John F)
Número de empleados2650
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 13
Dirección12400 High Bluff Drive
CiudadSAN DIEGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92130
Teléfono18583666900
Sitio Webhttps://www.tandemdiabetes.com/
Símbolo de cotizaciónTNDM
Fecha de salida a bolsaNov 13, 2013
Director ejecutivoSheridan (John F)
Ejecutivos de Tandem Diabetes Care Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John F. Sheridan
Mr. John F. Sheridan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
152.44K
+18.20%
Ms. Leigh A. Vosseller
Ms. Leigh A. Vosseller
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
74.98K
+13.32%
Ms. Susan M. Morrison
Ms. Susan M. Morrison
Executive Vice President, Chief Administrative Officer
Executive Vice President, Chief Administrative Officer
50.77K
+16.02%
Mr. Mark David Novara
Mr. Mark David Novara
Executive Vice President and Chief Commercial Officer
Executive Vice President and Chief Commercial Officer
40.32K
+6.60%
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
37.11K
+23.60%
Mr. Rick Carpenter
Mr. Rick Carpenter
Chief Technical Officer
Chief Technical Officer
30.92K
+18.25%
Mr. Jean-Claude (JC) Kyrillos
Mr. Jean-Claude (JC) Kyrillos
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
28.11K
+8.30%
Dr. Kathleen McGroddy-Goetz, Ph.D.
Dr. Kathleen McGroddy-Goetz, Ph.D.
Independent Director
Independent Director
26.61K
+32.91%
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Elizabeth A. Gasser
Ms. Elizabeth A. Gasser
Executive Vice President and Chief Strategy and Product Officer
Executive Vice President and Chief Strategy and Product Officer
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John F. Sheridan
Mr. John F. Sheridan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
152.44K
+18.20%
Ms. Leigh A. Vosseller
Ms. Leigh A. Vosseller
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
74.98K
+13.32%
Ms. Susan M. Morrison
Ms. Susan M. Morrison
Executive Vice President, Chief Administrative Officer
Executive Vice President, Chief Administrative Officer
50.77K
+16.02%
Mr. Mark David Novara
Mr. Mark David Novara
Executive Vice President and Chief Commercial Officer
Executive Vice President and Chief Commercial Officer
40.32K
+6.60%
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
37.11K
+23.60%
Mr. Rick Carpenter
Mr. Rick Carpenter
Chief Technical Officer
Chief Technical Officer
30.92K
+18.25%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Tandem Diabetes Care Inc?
Los cinco principales accionistas de Tandem Diabetes Care Inc son: Mr. John F. Sheridan
¿Cuántas instituciones poseen acciones de Tandem Diabetes Care Inc (TNDM)?
A fecha de 2026Q1, 666 instituciones poseen acciones de Tandem Diabetes Care Inc, con un valor de mercado combinado de aproximadamente 88.22M, lo que representa el 128.74% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -9960335.00.
¿Cuál es la mayor fuente de ganancias de Tandem Diabetes Care Inc?
El 2026Q1, el segmento empresarial Pump generó la ganancia más alta para Tandem Diabetes Care Inc, ascendiendo a 706.94M y representando el 69.67% de la ganancia total.